Accelerating enrollment with custom-tailored recruitment in neurological trials

From migraines to Alzheimer’s to major depressive disorders, this therapeutic area covers a vast landscape of challenges that patients face day in and day out. Effective patient recruitment in neurology requires deep expertise, a personalized approach, and a team of enrollment experts who understand the challenges unique to these patients.  

1nHealth takes full ownership of the enrollment process across this complex therapeutic area—making patient recruitment one less challenge for your next study.

0

Patients enrolled

0

Studies completed

0

+

Sites coordinated

Our​ difference​

Neurological clinical trials require​​ precision and sensitivity

Neurological diseases and disorders affect more than 3 billion people around the world.  

Neurological trials demand expertise and care with patients experiencing complex conditions. Our team has decades of combined experience across digital recruitment and clinical operations who excel at finding the right patients to meet your protocol’s needs.

At 1nHealth, we own the enrollment process so that you can focus on delivering results for a wide-ranging therapeutic area.

Your trial is unique, which means your recruitment solution should be too

Our expertise

Major Depressive Disorder

Major depressive disorder (MDD) is a leading cause of disability globally, affecting an estimated 264 million people. 

Characterized by persistent feelings of sadness, loss of interest, and impaired daily functioning, MDD significantly impacts quality of life. Its multifactorial etiology involves genetic, neurobiological, and environmental factors, including neurotransmitter imbalances, inflammation, and stress. 

Risk factors include a family history of depression, trauma, and chronic medical conditions. Despite available treatments like antidepressants and psychotherapy, many patients do not achieve adequate symptom relief.

Bipolar Disorder

Bipolar disorder (BD) is a chronic mood disorder characterized by extreme mood swings, including manic, hypomanic, and depressive episodes. 

Affecting approximately 1–2% of the global population, BD has significant genetic and environmental components. The disorder typically emerges in late adolescence or early adulthood and often results in significant functional impairment. 

During manic phases, individuals may experience elevated mood, impulsivity, and impaired judgment, while depressive episodes involve sadness, fatigue, and hopelessness. Current treatments include mood stabilizers, antipsychotics, and psychotherapy.

Post-Partum Depression

Postpartum depression (PPD) is a common and serious mood disorder affecting approximately 10–20% of women following childbirth, with varying degrees of severity.

Symptoms include persistent sadness, anxiety, irritability, sleep disturbances, and difficulty bonding with the baby, often leading to significant impairment in daily functioning.

The pathophysiology of PPD is multifactorial, involving hormonal changes, genetic predisposition, psychological stress, and social factors. While it is distinct from the “baby blues,” which are typically short-lived, PPD requires clinical intervention.

Our​ success​

"The 1nHealth team has been a pleasure to work with. The team there is highly competent, very responsive, and accommodating to changing needs. They were able to deliver a successful campaign increasing overall enrollment for our study."

Sponsor

Social Anxiety Disorder

Learn how 1nHealth finished with a 115% ICF increase after replacing the previous recruitment partner.
View Case Study

Early Allergen System Experience (EASE)

Learn how 1nHealth’s targeted digital strategies and expertise led to the successful early recruitment of 1,100 diverse participants for the Early Allergen System Experience (EASE) trial.

Hover to reveal top creative

Bipolar Disorder

Learn how 1nHealth was brought on as the third enrollment vendor and enrolled 24 patients in the first 12 weeks.
View Case Study

Vaping Cessation

Learn how 1nHealth enrolled 357 global patients across the United States, Canada, France, Germany, and the UK for adult vape users to become nicotine-free.
View Case Study

COVID-19 Registry

Learn how 1nHealth was able to register over 1,000 adults for a COVID-19 registry that required patients having contracted COVID in the past 7 days with no hospitalization.

Hover to reveal top creative

Our experience across other therapeutic areas

Your next trial is thoughtful, complex, and different. Your patient recruitment should be too.

From kick-off to last patient in, 1nHealth builds a reliable source of referred enrollments through proven recruitment programs and high-touch patient engagement.

Click each area to learn more.​

Enroll your next neurological clinical trial faster than you thought possible.